Scientists have shown that a new targeted therapy drug can extend the amount of time people with a subtype of glioma are on treatment without their cancer worsening. The finding suggests a possible new treatment option for people with the slow-growing but deadly brain tumor.
from Latest Science News -- ScienceDaily https://ift.tt/rbIseNx
0 Comments